Antifungal / Antimicrobial Activity

Usnic acid's antifungal crossover relevance and why it matters in this documentation set

Usnic acid is especially relevant here because it is not only an oncology compound.

Current research highlights broad-spectrum antifungal relevance across organisms such as:

Usnic acid 4 µg/mL blocked 71–88% of biofilm formation by azole-resistant and azole-sensitive Candida albicans and thinned mature films under confocal microscopy.
Against high-biofilm ocular coagulase-negative staphylococci, 31–62 µg/mL usnic acid cut nascent biofilm up to 81% but removed ≤45% once the film was mature.
Proposed mechanisms include oxidative burst inside biofilms.

Interpretation – Usnea is strong at preventing or thinning early biofilms, modest at eroding thick established ones.

UA is discussed as relevant to fungal 14-3-3 protein networks, virulence regulation, persistence, and survival.

That means the same compound may be biologically interesting in both tumour and fungal contexts.

Many compounds discussed in oncology have only vague antimicrobial claims.

UA is different.

Its fungal crossover logic is one of the reasons it fits naturally inside both the oncology and fungal-pathogen libraries.

This does not prove UA alone can clear deep fungal burden.

It does support serious interest in:

The antifungal side of UA is part of the real story, not a side note.

That is a major reason it deserves fuller treatment than a single short page.

Multifaceted Properties of Usnic Acid in Disrupting Cancer Hallmarks
https://pmc.ncbi.nlm.nih.gov/articles/PMC11505503/

A Potent and Selective Inhibitor of the Human Mitochondrial Pyruvate Carrier
https://pubs.acs.org/doi/10.1021/jacsau.3c00774